Home
/
Tonix Pharmaceuticals Holding Corp.
/
Financials
/
Quarterly
Tonix Pharmaceuticals Holding Corp. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Tonix Pharmaceuticals Holding Corp. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$3.29M
Nov 10, 2025
Q2
2025
Jun 30, 2025
$2.00M
Aug 11, 2025
Q1
2025
Mar 31, 2025
$2.43M
May 12, 2025
Q3
2025
Sep 30, 2024
$2.82M
Nov 10, 2025
Q2
2025
Jun 30, 2024
$2.21M
Aug 11, 2025
Q1
2025
Mar 31, 2024
$2.48M
May 12, 2025
Q3
2024
Sep 30, 2023
$3.99M
Nov 12, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($32.01M)
Nov 10, 2025
Q3
2025
Jun 30, 2025
($28.27M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($28.27M)
Aug 11, 2025
Q3
2025
Mar 31, 2025
($16.83M)
Nov 10, 2025
Q1
2025
Mar 31, 2025
($16.83M)
May 12, 2025
Q2
2025
Mar 31, 2025
($16.83M)
Aug 11, 2025
Q3
2025
Sep 30, 2024
($14.21M)
Nov 10, 2025
Q3
2025
Jun 30, 2024
($78.78M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($78.78M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($14.94M)
May 12, 2025
Q2
2025
Mar 31, 2024
($14.94M)
Aug 11, 2025
Q3
2025
Mar 31, 2024
($14.94M)
Nov 10, 2025
Q3
2024
Sep 30, 2023
($27.98M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($28.36M)
Aug 16, 2024
Q3
2024
Jun 30, 2023
($28.36M)
Nov 12, 2024
Q1
2024
Mar 31, 2023
($33.01M)
May 13, 2024
Q2
2024
Mar 31, 2023
($33.01M)
Aug 16, 2024
Q3
2024
Mar 31, 2023
($33.01M)
Nov 12, 2024
Q3
2023
Sep 30, 2022
($28.98M)
Nov 9, 2023
Q3
2023
Jun 30, 2022
($23.14M)
Nov 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($33.07M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($28.30M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($16.05M)
May 12, 2025
Q3
2025
Sep 30, 2024
($15.55M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($77.32M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($21.35M)
May 12, 2025
Q3
2024
Sep 30, 2023
($28.15M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($29.00M)
Aug 16, 2024
Q1
2024
Mar 31, 2023
($33.90M)
May 13, 2024
Q3
2023
Sep 30, 2022
($29.59M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($23.34M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($26.44M)
May 8, 2023
Q3
2022
Sep 30, 2021
($18.54M)
Nov 7, 2022
Q2
2022
Jun 30, 2021
($23.56M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($20.74M)
May 9, 2022
Q3
2021
Sep 30, 2020
($12.00M)
Nov 8, 2021
Q2
2021
Jun 30, 2020
($14.19M)
Aug 9, 2021
Q1
2021
Mar 31, 2020
($7.30M)
May 10, 2021
Q3
2020
Sep 30, 2019
($7.89M)
Nov 9, 2020
Q2
2020
Jun 30, 2019
($5.91M)
Aug 10, 2020